Focus
Pertosse e vaccini combinati
PERTUSSIS AND COMBINED VACCINES
G. Bartolozzi
Giugno 2002 - pagg. 363 -368
Abstract
Morbility from pertussis has significantly diminished over the last few years as a consequence
of immunisation. In 1997 there were no deaths due to pertussis, while in the 10
preceding years pertussis caused 47 deaths, 70% of them in children younger than 12
months. Coverage of pertussis immunisation is now satisfactory in Italy, while that for Hib is
still low. 6-valent vaccines including diphtheria, tetanus, pertussis, hepatitis B and Hib antigens
may be useful to improve the coverage.
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Wortis N, Strebel PM, Wharton M, et al. Pertussis
death: report of 23 cases in the United
States. Pediatrics 1996;97:607-12.
2. Eskola J, Ward J, Dagan R, et al. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999; 354: 2063-8.
3. Edwards KM, Decker MD. Combination vaccines. Infect Dis Clin N Am 2001;15:209-30.
4. Edwards KM, Decker MD, Mortimer EA. Pertussis vaccine. In: Plotkin SA, Orenstein WA. Vaccine. 3°ed. Philadelphia-Londra: WB Saunders, 1999:293-344.
5. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16:1901-6.
6. Cherry JD, Olin P. The science and the finction of pertussis vaccine. Pediatrics 1999;104: 1381-3.
7. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16:1907-16.
8. Olin P, Rasmussen F, Gustafsonn L, et al. Randomised controlled trial of two component, three-component, and five-component acellular pertussis vaccines compared with wholecell pertussis vaccine. Lancet 1997;350:1569- 77.
9. Olin P, Hallander HO, Gustafsson L, et al. How to make sense of pertussis immunogenicity data. Clin Infect Dis 20001;33(suppl. 4): S288-91.
10. Tinnion ON. Acellular vaccine for preventing whooping cough in children. The Cochrane Library 2001;2:CD001478.
11. de Melker HE, Conyn van Spaendonck MAE, Rumle HC. Pertussis in Netherlands: an ourbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 2000;3:348-57.
2. Eskola J, Ward J, Dagan R, et al. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999; 354: 2063-8.
3. Edwards KM, Decker MD. Combination vaccines. Infect Dis Clin N Am 2001;15:209-30.
4. Edwards KM, Decker MD, Mortimer EA. Pertussis vaccine. In: Plotkin SA, Orenstein WA. Vaccine. 3°ed. Philadelphia-Londra: WB Saunders, 1999:293-344.
5. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16:1901-6.
6. Cherry JD, Olin P. The science and the finction of pertussis vaccine. Pediatrics 1999;104: 1381-3.
7. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16:1907-16.
8. Olin P, Rasmussen F, Gustafsonn L, et al. Randomised controlled trial of two component, three-component, and five-component acellular pertussis vaccines compared with wholecell pertussis vaccine. Lancet 1997;350:1569- 77.
9. Olin P, Hallander HO, Gustafsson L, et al. How to make sense of pertussis immunogenicity data. Clin Infect Dis 20001;33(suppl. 4): S288-91.
10. Tinnion ON. Acellular vaccine for preventing whooping cough in children. The Cochrane Library 2001;2:CD001478.
11. de Melker HE, Conyn van Spaendonck MAE, Rumle HC. Pertussis in Netherlands: an ourbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 2000;3:348-57.